- Home
- CLRB vs LEDS Comparison
CLRB vs LEDS Comparison
Compare CLRB & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRB | LEDS |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 12.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | CLRB | LEDS |
|---|---|---|
| Price | $3.32 | $1.59 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.5K | 8.0K |
| Earning Date | 03-12-2026 | 01-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $44,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 824.43 |
| 52 Week Low | $2.45 | $1.41 |
| 52 Week High | $20.60 | $3.37 |
Technical Indicators
Market Signals| Indicator | CLRB | LEDS |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 38.03 |
| Support Level | $3.14 | $1.54 |
| Resistance Level | $3.42 | $1.62 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 56.06 | 17.07 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.